A novel scoring system for TIGIT expression in classic Hodgkin lymphoma

Clinical use of immune-checkpoints inhibitors (anti PD-1/PD-L1) resulted very effective for the treatment of relapsed/refractory classic Hodgkin Lymphoma (CHL). Recently, T cell Ig and ITIM domains (TIGIT) has been recognized as an immune checkpoint receptor able to negatively regulate T cell functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Annibali, Ombretta, Bianchi, Antonella, Grifoni, Alba, Tomarchio, Valeria, Tafuri, Mariantonietta, Verri, Martina, Avvisati, Giuseppe, Crescenzi, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007711/
https://www.ncbi.nlm.nih.gov/pubmed/33782477
http://dx.doi.org/10.1038/s41598-021-86655-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007711/
https://www.ncbi.nlm.nih.gov/pubmed/33782477
http://dx.doi.org/10.1038/s41598-021-86655-8

Ejemplares similares